Twist Bioscience: Guggenheim Maintains Buy Rating, Raises PT to $55 from $50

lunes, 30 de marzo de 2026, 11:35 am ET1 min de lectura
TWST--

Twist Bioscience: Guggenheim Maintains Buy Rating, Raises PT to $55 from $50

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios